Efficacy and safety of off-label direct oral anticoagulants vs. warfarin for left ventricular thrombus: an inverse probability of treatment weighting analysis

Efficacy and safety of off-label direct oral anticoagulants vs. warfarin for left ventricular thrombus: an inverse probability of treatment weighting analysis

ObjectiveTo evaluate the efficacy and safety of using off-label direct oral anticoagulants (DOACs) compared to warfarin for treating left ventricular (LV) thrombi using inverse probability-of-treatment weighting (IPTW) analysis.MethodsAn observational study of 302 eligible patients with newly diagno...

Full description

Saved in:

Bibliographic Details
Main Authors:	Taha Al-Maimoony, Khairallah Al-Matari, Abdulhafeedh Al-Habeet, Nouradden Noman Aljaber, Mohamad Al-Marwala, Salah Al-Hashmi
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-04-01
Series:	Frontiers in Cardiovascular Medicine
Subjects:	direct oral anticoagulants left ventricular thrombus warfarin vitamin K antagonist inverse probability of treatment weighting analysis
Online Access:	https://www.frontiersin.org/articles/10.3389/fcvm.2025.1465866/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficiency of the Left Atrial Appendage Thrombus Dissolution in Patients with Persistent Nonvalvular Atrial Fibrillation with Warfarin or Direct Oral Anticoagulants Therapy
by: E. S. Mazur, et al.
Published: (2021-11-01)

Comparison between DOACs and warfarin for left atrial thrombus in atrial fibrillation patients
by: Akihiro Sunaga, et al.
Published: (2025-08-01)

Identification of Anticoagulation Benefit Subgroups of Patients With Left Ventricular Thrombus
by: Zechen Liu, et al.
Published: (2025-06-01)

An unusual complication during anticoagulant therapy
by: M. T. Vatutin, et al.
Published: (2015-10-01)

The Effectiveness of Direct Oral Anticoagulation in the Treatment of Left Ventricular Thrombus in Noncompaction Cardiomyopathy: A Case Report
by: Ossama Maadarani, et al.
Published: (2025-07-01)

CYP2C9*2 and CYP2C9*3 allele variants of CYP2C9 cytochrome gene in St. Petersburg population, and their clinical role in warfarin anticoagulant therapy
by: O. V. Sirotkina, et al.
Published: (2004-12-01)

WARFARIN AND ITS IMPORTANCE IN THE ERA OF NEW ORAL ANTICOAGULANTS. ISSUES OF MONITORING THE EFFECTIVENESS AND SAFETY OF TREATMENT
by: S. Yu. Martsevich, et al.
Published: (2017-11-01)

SYNTHESIS, PHYSICO-CHEMICAL ANALYSIS AND PHARMACOLOGICAL ACTIVITY OF SOME DERIVATIVES OF WARFARIN
by: A. Z. Abyshev, et al.
Published: (2019-01-01)

Factors affecting target INR levels in homebound and ambulatory patients who use warfarin
by: Ozge Tuncer, et al.
Published: (2024-11-01)

Using the software «DAWN AC» for control of dosing warfarin in the special anticoagulation clinics
by: O. S. Napalkova, et al.
Published: (2015-06-01)

Nontraumatic warfarin-related intrapulmonary hemorrhage presenting as a lung mass
by: Hiroyuki Tsuchida, et al.
Published: (2020-04-01)

SAFETY OF LONGTERM THERAPY WITH WARFARIN: POSSIBILITY OF TREATMENT RENEWING AFTER HEMORRHAGIC COMPLICATIONS
by: E. S. Kropacheva
Published: (2016-01-01)

Temporal Changes in Long‐Term Outcomes of Venous Thromboembolism From the Warfarin Era to the Direct Oral Anticoagulant Era
by: Kazuhisa Kaneda, et al.
Published: (2024-08-01)

The Anticoagulation in Patients with Atrial Fibrillation: Rivaroxaban and Warfarin
by: I. Yu. Koroleva, et al.
Published: (2016-11-01)

Severe Airway Obstruction due to Massive Retropharyngeal Hematoma in a Warfarin-Taking Patient with a Normal International Normalized Ratio
by: Hyun Young Cho, et al.
Published: (2021-03-01)

Assessment of Knowledge and Training Needs for the Clinical Management of Warfarin Anticoagulation Among Physicians in China
by: Luo A, et al.
Published: (2025-02-01)

Efficacy and Safety of New Oral Anticoagulants versus Warfarin in the Resolution of Atrial Fibrillation with Left Atrial/Left Atrial Appendage Thrombus: A Systematic Review and Meta-Analysis
by: Guan-lian Mo, et al.
Published: (2025-01-01)

Left Ventricular Thrombosis: Current Perspective and Use of Direct Oral Anticoagulants
by: A. D. Aga, et al.
Published: (2023-01-01)

Anticoagulation quality with warfarin therapy, and associated factors among adult outpatients at public hospitals in nekemte town, western Ethiopia: a retrospective study
by: Firafan Shuma Teka, et al.
Published: (2025-04-01)

GENETIC FACTORS INFLUENCING THE EFFECTIVENESS AND SAFETY OF LONG-TERM ANTICOAGULANT THERAPY
by: T. V. Burkova, et al.
Published: (2013-06-01)

Sex-related differences in acute coronary syndrome: insights from an observational study in a Yemeni cohort
by: Muammar Yahiya Al-Assadi, et al.
Published: (2025-06-01)

Quality of Anticoagulation Management with Warfarin among Patients in Orotta National Referral Hospital, Asmara, Eritrea: A Retrospective Cross-Sectional Study
by: Natnael Russom, et al.
Published: (2022-10-01)

POTENTIAL OF PHARMACOGENETICS IN THE CORRECTION OF ANTICOAGULANT THERAPY AMONG PATIENT WITH PROSTHETIC HEART VALVES
by: I. Yu. Zhuravleva, et al.
Published: (2013-06-01)

Algorithm for the Choice of Anticoagulant for Patients with Atrial Fibrillation
by: Yu. P. Skirdenko, et al.
Published: (2020-05-01)

Is point-of-care accurate for indicating thrombolysis in anticoagulated patients on oral anticoagulation treatments?
by: Tatiana P. Bruch, et al.

Factors influencing nurses’ knowledge and competence in warfarin-drug and nutrient interactions and patient counseling practices
by: Maha Subih, et al.
Published: (2025-04-01)

Risk of postoperative bleeding following dental extractions in patients on antithrombotic treatment
by: Mohammed AlSheef, et al.
Published: (2021-11-01)

The Therapy with Oral Anticoagulants in Patients with Atrial Fibrillation in Outpatient and Hospital Settings (Data from RECVASA Registries)
by: M. M. Loukianov, et al.
Published: (2019-09-01)

Determining the effect of drug "Warfarin sodium" on toxicity indicators in an acute experiment
by: D.O. Hlavachek, et al.
Published: (2023-09-01)

An unusual thrombus in a patient with arrhythmogenic cardiomyopathy
by: Sezgin Atmaca, et al.
Published: (2025-03-01)

Assessing the knowledge of medical undergraduates on oral anticoagulation therapy
by: Chayna Sarkar, et al.
Published: (2023-09-01)

Decrease in Efficacy of Warfarin as a Result of Drug-Drug Interaction (Case Report)
by: N. T. Vatutin, et al.
Published: (2020-03-01)

Anticoagulation control for nonvalvular atrial fibrillation in a tertiary academic centre in Johannesburg
by: Vanessa Mogashoa, et al.
Published: (2024-10-01)

Analysis of Anticoagulant Therapy in the Elderly Patients, in Clinical Practice of Family Medicine Centers in the Kyrgyz Republic
by: S. M. Mamatov, et al.
Published: (2021-05-01)

LONG-TERM ANTICOAGULATION THERAPY IN SECONDARY PREVENTION OF ACUTE CORONARY SYNDROME: HOW TO CHOOSE THE PATIENT?
by: A. L. Komarov
Published: (2016-07-01)

Contribution of anticoagulant therapy adherence to the risk of complications of atrial fibrillation
by: Yu. P. Skirdenko, et al.
Published: (2019-03-01)

WARFARIN: PLACE IN THE ANTICOAGULANT THERAPY TODAY
by: N. A. Novikova, et al.
Published: (2016-07-01)

NEW ORAL ANTICOAGULANTS: FOCUS ON THE SAFETY
by: D. A. Napalkov, et al.
Published: (2015-09-01)

Thrombus composition and distribution patterns by thrombus volume in acute ischemic stroke
by: Jaeseob Yun, et al.
Published: (2025-08-01)

POSSIBILITY OF NOVEL ORAL ANTICOAGULANTS USAGE DURING ABLATION IN ATRIAL FIBRILLATION
by: B. A. Tatarsky, et al.
Published: (2014-12-01)